Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 | P49768 | 18/20 | 0.51 |
| ▸ | PSEN2 | P49810 | 18/20 | 0.51 |
| ▸ | APH1B | Q8WW43 | 18/20 | 0.51 |
| ▸ | NCSTN | Q92542 | 18/20 | 0.51 |
| ▸ | APH1A | Q96BI3 | 18/20 | 0.51 |
| ▸ | PSENEN | Q9NZ42 | 18/20 | 0.51 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554525 | 0.89 | C5AR1 (0.53) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6831782 | 0.86 | C5AR1 (0.65) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6828296 | 0.85 | C5AR1 (0.57) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6828425 | 0.83 | PSEN1 (0.62) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6828359 | 0.81 | C5AR1 (0.51) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6553119 | 0.76 | POLB (0.50) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6553183 | 0.76 | PSEN1 (0.49) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6553189 | 0.74 | C5AR1 (0.70) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6555482 | 0.72 | PSEN1 (0.63) | PSEN1PSEN2APH1BNCSTNAPH1A | |
| SCHEMBL6831152 | 0.70 | C5AR1 (0.76) | PSEN1PSEN2APH1BNCSTNAPH1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040023938-A1 | Sulfonamide derivatives | TABUCHI TAKANORI (JP) | 2004-02-05 | — | — | US | disclosed |
| US-6586617-B1 | Nontoxic microbiocides such as 4'-chloro-N-ethyl-2'-nitro-p-toluenesulfonanilide, for agricultural or horticultural, prepared by alkylation or nitration | SUMITOMO CHEMICAL TAKEDA AGRO COMPANY, LIMITED (JP) | 2003-07-01 | — | — | US | disclosed |
| EP-1174028-A1 | SULFONAMIDE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2002-01-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040023938-A1 | Sulfonamide derivatives | FPR1, MRM1, SULT1E1 | PSEN1 2647/4885PSEN2 3366/4885APH1B 1681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.